Funded by NIH STTR/SBIR Program
- Awarded the NIH Small Business Technology Transfer (STTR) Phase 1 grant in 2017.
- Awarded the NIH SBIR Phase 2 grant in 2020.
About US
Hura Imaging is a medical imaging software company focusing on AI innovations for imaging guided treatment.
OUR MISSION
Improve the safety, efficiency, and quality of the medical imaging process, in particular for imaging-guided treatment.
HuraCTP® TECHNOLOGY
First and the only FDA cleared denoising software dedicated for CT perfusion (CTP), physics-based AI algorithm with superior performance for improving image quality .
EXAMPLE
Hura CTP® improves image quality of CTP images for all CT models, validated by rigorous multi-center study.
DV.Target® TECHNOLOGY
Top FDA approved deep learning (DL) product on the market. Results of years of original research in the DL algorithm. Superior performance for time saving and contouring results.
EXAMPLE
DV.Target Full Body of OARs.
CereFlow® TECHNOLOGY
First comprehensive commercial software dedicated for arterial spin labeling (ASL) perfusion MRI.
Supported by multiple studies and publications.
Supported by multiple studies and publications.
EXAMPLE
CereFlow® report for multiparametric perfusion maps with auto-processing of multi-delay pCASL data.
Our PUBLICATIONS
All PublicationsOur BENEFITS
Hura technologies will significantly improve the diagnostic imaging quality for patients with cardiovascular disease and stroke, dementia, cancer as well as pediatric patients.
Patients
Improve safety and reduce the use of radiation/ contrast agent
Clinicians
Improve diagnostic accuracy and efficiency for treatment planning
Payers
Reduce cost and improve healthcare service provision and quality
FDA & Strategic Acquires
Increase regulatory compliance, improve function and competitiveness of equipment to drive sales
NATIONAL INSTITUTE OF HEALTH
Our Timeline
Our Fantastic Team
Hura is operated by World Leaders in the Medical Imaging Sector and
maintains exclusive dose reduction Intellectual Property (IP).
maintains exclusive dose reduction Intellectual Property (IP).
Danny JJ Wang, PhD, MSCE
Founder & Chief Executive Officer
Dr. Wang is a world leading expert in medical imaging with over 20 years of experience. Dr. Wang also maintains longstanding R&D collaborations with large OEMs including Philips, Siemens, Samsung and Neusoft.
Marc Korczykowski, MB, MA
Co-Founder & Chief Commercial Officer
Mr. Korczykowski served as a Senior Advisor at Brookline Capital Markets in NY and Senior Director, Clinical Operations at a publicly traded Biotech Company. He has 15 years of experience advancing clinical diagnostics and drug discovery & development efforts.
Jerry Liu, MBA
Co-Founder & Chief Operating Officer
20 years Marketing & Investment Experience
Jeffry Alger, PHD
Chief Scientist
Adjunct Professor of UCLA David Geffen School of Medicine
Narisu Bai, MS
Chief Technology Officer
10 years AI and Software Development
Joy Peng, MS
Senior Product Manager
8 years Medical Software Development
David S. Liebeskind, MD
Scientific Advisor and Consultant
Director of the UCLA Stroke Center
Professor of Neurology
UCLA Department of Neurology
Director, UCLA Stroke Center
Director, Neurovascular Imaging Research Core
An Liu, PhD
Medical Advisor
Clinical Professor, Department of Radiation Oncology. Clinical Professor and Director, Division of Radiation Physics, City of Hope
Hee Kwon Song, PhD
Chief Scientist
Associate Professor of Radiologic Science at University of Pennsylvania
John Detre, MD
Chief Medical Advisor
Director at Center for Functional NeuroImaging. Professor of Neurology & Radiology at University of Pennsylvania
Michael McNitt-Gray, PhD
Chief Science Advisor
Member of Science Advisory Board
Professor of Radiology; Director of Physics & Biology in Medicine Graduate Program; UCLA David Geffen School of Medicine
Fabien Scalzo, PhD
Senior AI Scientist
Associate Professor of Computer Sciences, Pepperdine University
Thomas Martin, PhD
R&D Scientist, Physics
Medical Physicist
Xin J. Qiao, MD, MS
General Manager & Chief Compliance Officer
Brian Walsh, MS, MBA
Chief Commercial Advisor
Chief Commercial Advisor
& National Institute of Health Advisor
Samantha Ma, MS
R&D Scientist, Artificial Intelligence
Ph.D. Candidate in Biomedical Engineering at University of Southern California
Arun Baalaaji
Intern in DL and Medical Image Analysis
Dinesh Kumar Gnanasekaran
Intern in DL and Medical Image Analysis
SIGNIFICANT INNOVATION IN CANCER CARE
Our Partners
